Stock Price
1,299.00
Daily Change
-15.70 -1.19%
Monthly
-3.34%
Yearly
-12.97%
Q1 Forecast
1,289.06

Cipla reported INR140.3M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Arca Biopharma USD 0 0 Mar/2025
Capricor Therapeutics 581K 581K Dec/2024
Cara Therapeutics 43.75M 4.8M Jun/2025
Cipla INR 140.3M 8.5M Dec/2025
Dr.Reddys Laboratories INR 944M 37M Dec/2025
Esperion Therapeutics USD 22.64M 585K Dec/2025
Immunic 400K 400K Dec/2024
Infinity Pharmaceuticals USD 45K 0 Jun/2023
Minerva Neurosciences USD 2.31M 60K Jun/2024
Nektar Therapeutics USD 6.02M 420K Sep/2024
Sangamo BioSciences 97.56M 11.39M Jun/2025
Sun Pharmaceuticals INR 998.6M 250.6M Sep/2025
TherapeuticsMD USD 20K 25K Sep/2023
UPL INR 7.74B 210M Dec/2025